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Abstract
Modular nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) enzymatic 
assembly lines are large and dynamic protein machines that generally effect a linear sequence of 
catalytic cycles. Here we report the heterologous reconstitution and comprehensive 
characterization of two hybrid NRPS-PKS assembly lines that defy many standard rules of 
assembly line biosynthesis to generate a large combinatorial library of cyclic lipodepsipeptide 
protease inhibitors called thalassospiramides. We generate a series of precise domain-inactivating 
mutations in thalassospiramide assembly lines and present evidence for an unprecedented 
biosynthetic model that invokes inter-module substrate activation and tailoring, module skipping, 
and pass-back chain extension, whereby the ability to pass the growing chain back to a preceding 
module is flexible and substrate-driven. Expanding bidirectional inter-module domain interactions 
could represent a viable mechanism for generating chemical diversity without increasing the size 
of biosynthetic assembly lines and challenges our understanding of the potential elasticity of 
multi-modular megaenzymes.
Modular nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) enzymes 
are molecular-scale assembly lines that construct complex polymeric products, many of 
which are useful to humans as life-saving drugs. The first characterized assembly lines 
exhibited an elegant co-linear biosynthetic logic, whereby the linear arrangement of 
functional units, called modules, along an NRPS or PKS polypeptide directly correlates to 
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the chemical structure of the product1. The PKS giving rise to the antibiotic erythromycin2 
and the NRPS producing the antibiotic daptomycin3 are two such examples. The core 
components of an NRPS or PKS assembly line elongation module include, respectively, 
condensation (C) or ketosynthase (KS) domains catalyzing chain extension, adenylation (A) 
or acyltransferase (AT) domains for substrate selection, and thiolation (T) domains for 
covalent substrate tethering. Optional tailoring domains such as methyltransferase (MT), 
ketoreductase (KR), or dehydratase (DH) domains, if present, chemically modify building 
blocks or chain-extension intermediates. This one-to-one correlation between product 
moieties and assembly line modules with the requisite catalytic domains is one feature that 
makes NRPS/PKS enzymes among the largest proteins found in nature.
However, it is now clear that many assembly lines do not strictly abide by the rules of co-
linearity. A phylogenetically distinct class of modular PKSs are trans-AT PKSs, which do 
not directly encode AT domains within modules but instead as stand-alone enzymes that act 
in trans4. A separate type of NRPS, referred to as a nonlinear NRPS, deviates from the 
standard core domain arrangement of C-A-T and reuses a single domain more than once5. 
Several nonlinear NRPSs possess modules missing A domains and are presumably loaded 
by A domains from upstream modules6-10. Leveraging domain activities in trans or from 
different modules reduces the size of biosynthetic assembly lines and thus may represent a 
mechanism for minimizing modular assembly lines without sacrificing product complexity.
A particularly intriguing set of hybrid NRPS-PKS assembly lines that are both nonlinear and 
trans-AT are those responsible for the biosynthesis of the thalassospiramides, a large group 
of immunosuppressive cyclic lipodepsipeptides11-13. Thalassospiramide NRPS-PKS genes 
have been identified in several marine Rhodospirillaceae bacteria and exhibit distinct 
architectures that range in domain and module “completeness”13. While it is still unclear 
whether all configurations are functional, thalassospiramide assembly lines representing the 
most “complete” and “incomplete” architectures are both capable of producing a large 
combination of lipodepsipeptides that vary in fatty acid and amino acid composition, order, 
and length12. Previous work identifying these NRPS-PKS genes and structurally 
characterizing their numerous and diverse chemical products11-13 led us to hypothesize that 
these assembly lines must operate with an unprecedented degree of nonlinearity. 
Furthermore, we posited that in order to generate their chemical products, thalassospiramide 
assembly lines must catalyze one or two rounds of pass-back chain extension, where the 
chain-extension intermediate is passed from a downstream module back to an upstream 
module within the same polypeptide.
Here, we report a comprehensive characterization of the thalassospiramide biosynthetic 
machinery from α-proteobacteria Thalassospira sp. CNJ-328 and Tistrella mobilis 
KA081020-065, which represent the most “complete” and “incomplete” assembly line 
architectures, respectively13. We present an experimentally supported and mechanistically 
novel biosynthetic model that invokes inter-module substrate activation and tailoring, 
module skipping, and pass-back chain extension, whereby the ability to pass the growing 
chain forward or backward is flexible and influenced by the identity and chain length of the 
chemical intermediate. These newly described features accentuate the potential 
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bidirectionality and flexibility of multi-modular megaenzymes and reveal new engineering 
opportunities and structural considerations.
Results
Cloning and heterologous expression of ttc and ttm.
Close inspection of the thalassospiramide ttc and ttm gene clusters revealed that the 
NRPS/PKS genes from Thalassospira and Tistrella, respectively, occupy completely 
different genomic contexts (Fig. 1a,b, Supplementary Table 1). Ttc also includes a 4’-
phosphopantetheinyl transferase (PPTase), TtcD, for which there is no homolog in ttm. 
Notably absent from the genomic vicinity of both pathways are any genes encoding stand-
alone AT or A domains (Supplementary Table 1), although both assembly lines possess a 
trans-AT PKS module and Ttm contains two NRPS modules without A domains. We chose 
to clone a broader range for ttc and a more limited range for ttm (Fig. 1a,b).
To directly clone these gene clusters, a new bacterial artificial chromosome (BAC)-based 
transformation-associated recombination (TAR) cloning vector, pCAP-BAC (pCB), was 
designed and constructed to enable stable maintenance of large constructs in Escherichia coli 
(Supplementary Fig. 1). pCB lacks host-specific integration elements, which can be 
introduced after cloning, to make it easier to retrofit cloned pathways with integration 
elements for different hosts. Following successful cloning of ttc, heterologous expression 
was attempted but never achieved in E. coli, despite efforts to perform promoter refactoring, 
stabilize protein expression, and co-express the pathway with various promiscuous PPTases 
(Supplementary Fig. 2). Thus, we constructed a Pseudomonas integration cassette containing 
the Int-B13 site-specific recombinase14 and introduced it into the vector backbone to 
generate pCB-ttc-int (Supplementary Fig. 1). This construct was successfully integrated into 
the genome of Pseudomonas putida EM38315 (Supplementary Fig. 3). The same procedure 
was used for ttm, and expression of both gene clusters in P. putida was successful as 
evidenced by detection of the representative product thalassospiramide A (1) (Fig. 1c, 
Supplementary Fig. 4). This validated that the Ttc and Ttm assembly lines do not require 
additional pathway-specific enzymatic components, beyond what was transferred to the host 
and supplied through primary metabolism. To our knowledge, this is the first report of 
successful heterologous expression of a trans-AT pathway without co-transfer of a cognate 
AT. Our current hypothesis as to why expression was successful in P. putida but not in E. 
coli is that the P. putida primary metabolic AT is capable of interfacing with the trans-AT 
PKS modules, while the AT from E. coli is not.
Reconstitution of thalassospiramide structural diversity.
We next explored whether the heterologously expressed Ttc and Ttm clusters could 
reproduce the full suite of thalassospiramide chemical diversity. Thalassospiramide cyclic 
lipodepsipeptides can be grouped into four categories based on their chemical structures and 
biosynthetic origin11-13 (Fig. 2). Products of Ttc can incorporate serine, phenylalanine, or 
tyrosine as the first amino acid residue (colored blue in Fig. 2), which can be extended by a 
single ketide unit to generate “B-like” as opposed to “A1-like” thalassospiramides. 
Alternatively, Ttm incorporates serine or valine in the first position, then includes or omits a 
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valine residue (colored red in Fig. 2) to generate “A4-like” or “E-like” thalassospiramides, 
respectively. Both assembly lines produce “A-like” thalassospiramides at greater relative 
abundance than their “B-like” or “E-like” counterparts.
Additional elements that contribute to structural diversity include the N-terminal fatty acid, 
which is predominantly an atypical C10:1(Δ3) fatty acid, and the pattern of N-methylation, 
which is predominantly limited to the final tyrosine residue of the cyclic peptide core but can 
also extend to the adjacent valine residue for products of Ttc and further to valine within the 
linear peptide for Ttm (Fig. 2). Finally, the number of linear Ser-C2-Val units (4-amino-3,5-
dihydroxy-N-pentanyl-valine, colored green in Fig. 2) can be 0, 1, or 2 for both assembly 
lines, which presumably arises from passage of chain-extension intermediates from module 
4 back to module 2 or from module 5 back to module 3. Based on the different possible 
combinations of these variables, each assembly line can theoretically generate well over 100 
compound analogs; several dozen compounds are routinely detected from small (50 mL) 
cultures of producing organisms using mass spectrometry.
LC-MS-MS analysis revealed that nearly all analogs detected from the native producers are 
also produced by the heterologous host, with some subtle differences in relative production 
levels (Supplementary Fig. 5). Overall titers of most analogs are comparable between native 
strains and host and in some cases greater in the host (Supplementary Fig. 5).
Characterization of non-assembly line genes.
To determine whether co-transferred genes beyond the core NRPS/PKS genes affect 
thalassospiramide titer or product distribution, we performed targeted deletions of all non-
assembly line genes within ttc. Previous work using the broad-host-range vector, pCAP05 
(ref. 16), demonstrated that no upstream genes (−7 through −1) are essential, although 
heterologous expression using this vector produced low yields (Supplementary Fig. 6a) and 
proved to be genetically unstable over time. Targeted deletion of ttc −1, +1, +2, +3, and +4 
in the stable pCB-ttc-int expression construct had no impact on thalassospiramide 
production; however, deletion of the gene encoding the putative PPTase TtcD resulted in an 
approximately five-fold reduction in thalassospiramide A (1), which was restored upon 
genetic complementation of ttcD (Supplementary Figs. 6 and 7). This observation suggests 
that the single native P. putida PPTase is capable of activating Ttc carrier proteins, albeit not 
as effectively as TtcD. The P. putida PPTase is clearly capable of activating Ttm carrier 
proteins, as no cognate PPTase is encoded within ttm, and thalassospiramides are still 
produced in the heterologous host. However, co-expression of ttcD with ttm resulted in an 
approximately two-fold increase in levels of thalassospiramide A (1) (Supplementary Figs. 6 
and 7). Quantitative analysis suggests that the PPTase TtcD favorably biases production of 
analogs that incorporate one or more linear Ser-C2-Val units (n≥1), particularly for Ttm, as 
ttcD co-expression actually decreases production of C2 (6) and E4 (25) (n=0) 
(Supplementary Fig. 7). This result suggests that TtcD-catalyzed phosphopantetheinylation 
of TtmA carrier proteins predisposes TtmA to perform pass-back chain extension at the 
expense of linear assembly through an unknown mechanism.
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Inactivation and testing of assembly line domains.
Taken together, the results of the heterologous expression and gene deletion experiments 
strongly suggest that thalassospiramide structural diversity is generated directly from the 
multi-modular assembly line itself and does not involve accessory enzymes beyond what is 
provided from primary metabolism. Although certain modules appear to be missing domains 
based on retro-biosynthetic analysis of thalassospiramide chemical structures, all necessary 
core and tailoring domains are present somewhere along the assembly line, including a DH 
domain in module 4 of both systems that was not previously annotated (Fig. 2, 
Supplementary Fig. 8). Thus, we set out to investigate the predicted inter-module activity of 
assembly line domains.
Our initial approach leveraged gene deletion and complementation tools, focusing first on 
the smaller ttcC that encodes the last four domains of terminal module 6. Despite it 
harboring the lone assembly line MT domain, some thalassospiramides, such as A8 (5), are 
unusual in containing a ‘misplaced’ penultimate N-methylated valine residue in addition to 
the conserved terminal N-methylated tyrosine. Although MTs are usually positioned at the 
C-terminus of interrupted A domains17, MT6 is positioned at the N-terminus of A6 
(Supplementary Fig. 8d). To explore whether MT6 can methylate amino acids activated by 
both the A5 and A6 adenylation domains, we deleted ttcC, resulting in complete loss of 
thalassospiramide production. Complementation with wild-type ttcC restored 
thalassospiramide production, while complementation with a mutant encoding TtcC-G234D, 
in which MT6 has been selectively inactivated, resulted in dramatic reduction and complete 
loss of thalassospiramides A (1) and A8 (5), respectively, and concomitant formation of a 
new product with HR-MS and MS/MS spectra consistent with desmethyl thalassospiramide 
A, or thalassospiramide A15 (26) (Supplementary Table 2, Supplementary Fig. 9). The same 
result was observed for all analogs, resulting in the formation of a series of desmethyl cylic 
lipodepsipeptides. This confirms our hypothesis that MT6 can act within the upstream 
module 5 of TtcB. Furthermore, it suggests that pass-back chain extension occurs between 
modules 4 and 2 as opposed to 5 and 3, as promiscuous methylation is confined to the cyclic 
valine residue for Ttc. If linear valine residues were installed by module 5, promiscuous 
methylation should extend to these positions; however, we never observe this for products of 
Ttc. As module 5 of Ttm does not possess an A domain and presumably borrows the activity 
of A2, this could explain why promiscuous methylation can extend to upstream valine 
residues for Ttm but not Ttc.
We attempted to use the same approach to characterize other thalassospiramide domains; 
however, efforts to perform PCR mutagenesis in ttcA, which is over 6.5 kb, and ttcB and 
ttmA, which are both over 15.5 kb, were ultimately unsuccessful. Therefore, we established 
new methodology combining oligo recombineering with CRISPR-Cas9 counter-selection for 
facile introduction of point mutations to large DNA constructs cloned into the pCB vector 
backbone (Supplementary Fig. 10). Using this method, we selectively inactivated a series of 
assembly line domains (Supplementary Fig. 11) to directly interrogate their role in 
thalassospiramide biosynthesis.
Zhang et al. Page 5
Nat Chem Biol. Author manuscript; available in PMC 2020 April 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Consistent with our annotation of C1a of TtcA as a starter C domain responsible for fatty 
acylation of the first amino acid residue18, C1a inactivation completely abolished production 
of all thalassospiramides (Fig. 3a). We did not detect any masses corresponding to core 
peptides lacking an N-terminal fatty acid, suggesting that the assembly line can only 
generate lipopeptide products. In contrast, inactivation of A1a using two different point 
mutations, TtcA-G631D and TtcA-K972A, resulted in essentially complete loss of all 
thalassospiramides incorporating phenylalanine or tyrosine as the first residue but 
maintained or enhanced production of analogs incorporating serine in the first position (Fig. 
3a). Inactivation of A3 using the analogous lysine to alanine mutation (TtcB-K2045A) 
resulted in complete loss of thalassospiramide production, as did selective inactivation of T1a 
(Fig. 3a). These results suggest that the serine residue adenylated by A3 is directly loaded 
onto T1a during biosynthesis of analogs that incorporate serine as the first amino acid 
residue.
We hypothesized that “B-like” thalassospiramides from Ttc arise through PKS module 1b 
and, correspondingly, that “A1-like” thalassospiramides arise through module 1b skipping. 
Consistent with that hypothesis, mutation of the active site cysteine of KS1b to alanine 
resulted in complete loss of “B-like” analogs but maintained production of “A1-like” 
analogs, although some yields were slightly reduced (Fig. 3a). Surprisingly, although AT1b 
inactivation (TtcA-S1728A) reduced production of “B-like” analogs, almost all could still be 
detected by LC-MS at ~8-24% of wild-type production levels (Fig. 3a). As the AT1b 
mutation is expected to abolish enzymatic activity and the assembly line has no other AT 
domains, we propose that the module 4-interacting trans-AT can partially complement AT1b.
We previously hypothesized that the tandem T domains in module 4 might be important for 
determining whether chain-extension intermediates are passed forward or backward12, 
although literature precedents indicated that multiple T domains do not change product 
identity but instead increase flux or yield19. We attempted to use the same oligo 
recombineering/CRISPR-Cas9 method to selectively inactivate T4a and T4b. However, 
CRISPR-Cas9 targeting did not result in oligo incorporation but instead recombination 
across the two very similar T domain sequences to generate an in-frame deletion of residues 
3511 to 3596 in TtcB. The resultant mutant protein contained only a single chimeric T 
domain composed of 46% of the N-terminus of T4a and 54% of the C-terminus of T4b 
(Supplementary Fig. 11). Transfer of this construct to the heterologous host revealed that all 
thalassospiramide analogs could still be produced, including those incorporating linear Ser-
C2-Val units arising from pass-back chain extension, albeit in decreased yields (Fig. 3a). 
This result proves that tandem T domains are not essential for bi-directional chain extension. 
Moreover, production of all analogs was affected equally, supporting the flux hypothesis.
Finally, we predicted that “E-like” thalassospiramides produced by Ttm arise from module 2 
skipping, analogous to module 1b skipping in Ttc. Thus, if pass-back chain extension occurs 
through modules 5 and 3, C2 inactivation in Ttm would preserve production of all “E-like” 
analogs, as C2 is completely skipped in this model. While C1 inactivation abolished 
production of all thalassospiramides, C2 inactivation dramatically reduced and completely 
abolished production of thalassospiramides E (23) and E1 (24), respectively (Fig. 3b). This 
result confirms our hypothesis that most pass-back events occur between modules 4 and 2, 
Zhang et al. Page 6
Nat Chem Biol. Author manuscript; available in PMC 2020 April 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
as levels of “E-like” analogs were not preserved. Furthermore, we observed a greater than 
100-fold increase in levels of thalassospiramide E4 (25), suggesting that the inability to pass 
growing chains back via C2 forces the assembly line to pass intermediates forward, resulting 
in enhanced production of the “premature” termination product E4 (25) (Fig. 3b). However, 
we also observed the formation of two new compounds not previously detected with HR-MS 
and MS/MS spectra consistent with the structures of thalassospiramides E5 (27) and E6 
(28), indicating that pass-back between modules 5 and 3 can occur but correlates with 
additional substrate dehydration by module 4 (Fig. 3c, Supplementary Table 2).
Models for thalassospiramide biosynthesis.
The results of Ttm C2 inactivation provide a clear mechanistic insight into the flexibility and 
control of pass-back chain extension during thalassospiramide biosynthesis, as illustrated in 
Figure 4. Selective inactivation of C2 does not affect early stages of “E-like” 
thalassospiramide biosynthesis, during which A2 loads T1 with valine and then module 2 is 
skipped following appendage of the N-terminal fatty acid. Assembly then proceeds through 
modules 3 and 4, but the chain-extension intermediate does not undergo immediate 
dehydration and may not be directly accessible to DH4. Now, the assembly line would 
normally pass the chain-extension intermediate from module 4 back to module 2 via C2, 
which is favored based on product distribution, as thalassospiramide E4 (25) is normally 
produced at very low abundance. We propose that the assembly line C domains play an 
important role in “measuring” intermediate chain length, promoting donation of the module 
4 intermediate backward to module 2 instead of forward to module 5. However, C2 
inactivation forces the chain-extension intermediate forward, making it accessible to DH4 
before it enters module 5. Once within module 5, the intermediate would normally proceed 
directly to module 6, resulting in formation of thalassospiramide E4 (25). Consistent with 
this proposal, C2 inactivation drives a substantial increase in levels of E4 (25) compared to 
wild-type. However, chain length can also be “measured” at the donor site of C6 (as C6 
usually accepts donor substrates of longer chain length), prompting the assembly line to 
catalyze pass-back of a subset of intermediates that have already undergone dehydration 
from module 5 back to module 3, resulting in eventual formation of new products E5 (27) 
and E6 (28). This result provides additional evidence that the substrate becomes accessible 
to DH4 just as it is passed forward to module 5 and dehydration is a passive result of forward 
chain extension, since a model that invokes DH4 gating of module 5 entry would not be 
consistent with the observed increase in levels of E4 (25) or formation of E5 (27) and E6 
(28). Furthermore, it suggests that biosynthesis is flexible and controlled by a mechanism 
that measures intermediate chain length. If we assume that dehydration of the hydroxyl 
group within the linear unit is a signature for module 5 progression, there is evidence that 
pass-back between modules 5 and 3 occurs at low frequency under normal conditions, 
perhaps as an additional checkpoint, as we can detect thalassospiramides E7 (29), E8 (30), 
and E9 (31) by LC-MS (Supplementary Table 2), which are all produced by wild-type Ttm 
and have undergone additional rounds of “premature” dehydration.
We can also propose a full model for thalassospiramide A (1) biosynthesis via Ttc (Fig. 5). 
T1a is preferentially adenylated with serine through the downstream A3 domain. To our 
knowledge, this is the first report of an A domain activating a carrier protein within an 
Zhang et al. Page 7
Nat Chem Biol. Author manuscript; available in PMC 2020 April 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
upstream module that already possesses its own active A domain12. Subsequently, module 
1b is skipped during formation of “A1-like” analogs. Normal chain extension proceeds from 
modules 2 to 4, at which point we hypothesize that the substrate is sequestered from DH4 
activity and module 5 entry based on chain length. We propose that during the formation of 
“B-like” thalassospiramides, ketoreduction to generate the upstream statine-like amino acid 
residue occurs at this time, analogous to dual ketoreduction of two disparate positions 
catalyzed by KR3 of PksJ during bacillaene biosynthesis20. The chain-extension 
intermediate within module 4 is then passed back to module 2 via C2, where it undergoes 
another round of linear chain extension through modules 2 to 4 (Fig. 5). Now, the 
intermediate has reached “sufficient” chain length and becomes accessible to DH4 before 
transfer to module 5 via C5. MT6 promiscuously methylates valine residues installed by 
module 5 to generate analogs such as thalassospiramide A8 (5). Finally, normal progression 
through modules 5 and 6 results in the formation of thalassospiramide A (1), the most 
abundant product of both Ttc and Ttm.
Discussion
Modular assembly lines are large and dynamic enzymes that undergo dramatic domain 
conformational rearrangements during a single catalytic cycle21-24. However, whether multi-
modular enzymes adopt a rigid, supermodular architecture25 or a more flexible 
configuration26 remains in debate. In this work, we demonstrate the ability of multi-modular 
assembly lines to catalyze bidirectional and nonlinear passage of chain-extension 
intermediates, favoring a more flexible arrangement.
Several new features of multi-modular NRPS/PKS biosynthesis are described in this work. 
Thalassospiramide assembly lines catalyze several instances of inter-module substrate 
activation and tailoring. While A domain supplementation has been previously reported6-10, 
prior examples have been limited to upstream domains supplementing downstream modules, 
often encoded on separate proteins, and only within modules that lack their own A domains. 
For Ttc, A3 adenylates T1a with serine more frequently than A1a does with phenylalanine or 
tyrosine, although A1a is active and participates in biosynthesis of numerous 
thalassospiramide analogs. For Ttm, both A2 and A3 deliver substrates to T1, but only A3 
adenylates T5. Furthermore, only A2 loads T1 if module 2 is skipped, as all “E-like” analogs 
incorporate valine as the first amino acid, perhaps due to the specificity of C327. MT6 
promiscuously methylates valine residues activated by A5 of Ttc and A2 of Ttm. Finally, the 
trans-AT interacting with module 4 can partially supplement lost AT1b activity in Ttc. 
Complementation of lost cis-AT activity with cis-ATs from other modules or non-cognate 
trans-ATs has been previously observed in the 6-deoxyerythronolide B PKS synthase28.
Thalassospiramide assembly lines also catalyze programmed module skipping. Forward 
module skipping has been previously observed in PKS29-31 and NRPS32-34 systems, both 
naturally and as a byproduct of engineering. Ttc and Ttm catalyze analogous skipping of 
PKS module 1b and NRPS module 2, respectively, although NRPS module 2 does not sit at 
an enzyme junction but is embedded within a very large polypeptide. Perhaps as a result, 
skipping is favored in Ttc but disfavored in Ttm, based on product distribution.
Zhang et al. Page 8
Nat Chem Biol. Author manuscript; available in PMC 2020 April 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Finally, thalassospiramide assembly lines catalyze pass-back chain extension. To our 
knowledge, this mechanism has not been previously reported in modular assembly line 
systems, although it is analogous to “iteration” observed in the fungal beauvericin and 
bassianolide synthetases35, where intermediates are passed back and forth between adjacent 
modules. Consistent with previous findings, tandem T domains in thalassospiramide 
assembly lines increase flux19 but are not mechanistic determinants of pass-back chain 
extension. This result is also consistent with the observation that the thalassospiramide 
assembly line from Oceanibaculum pacificum contains only a single T domain in module 4 
and can still produce thalassospiramide A (1)13. There is no evidence that additional T 
domains promote “stalling” to allow for additional tailoring reactions, as having a single T 
domain in module 4 does not change product distribution but decreased levels of all analogs 
equally.
Under normal conditions, thalassospiramide intermediates are passed from module 4 back to 
module 2 via C2. Upon C2 inactivation, we observe pass-back chain extension from module 
5 back to module 3 via C3. This suggests that the assembly line is flexible and can respond 
to perturbation, trying to “correct” for aberrant intermediate chain length caused by C2 
inactivation by passing back through C3, which, like C6, is specific for accepting 
intermediates with C-terminal valine residues. Our results are consistent with recent findings 
that multi-modular NRPSs can be “mixed and matched” if the specificity and relative 
position of downstream C domains are maintained27. It also suggests that assembly lines 
must possess some symmetry for pass-back chain extension to occur. While all NRPS 
modules possess mechanisms to control the timing of chain extension to prevent 
misinitiation36,37, thalassospiramide modules have the added ability to accept longer 
intermediates from nonsequential modules.
Perhaps more importantly, how physical proximity between upstream C domains and 
downstream T domains is achieved during pass-back chain extension remains unclear. We 
cannot predict the plasticity of the hybrid thalassospiramide assembly line proteins based on 
their primary amino acid sequence alone (Supplementary Fig. 8). Although we can assume 
that TtcA, TtcB, and TtmA are homodimeric due to the dimeric nature of KS and many 
linker domains, we do not know whether oligomerization impacts thalassospiramide 
assembly, although it is tempting to suggest that higher-order architecture helps facilitate 
nonlinear transfer.
It is curious that although the early stages of thalassospiramide biosynthesis are flexible, 
resulting in production of lipopeptides with a high degree of N-terminal structural diversity, 
the final stages are rather fixed. The C-terminal cyclic depsipeptide core of all 
thalassospiramide analogs is highly conserved, particularly the 12-membered ring and the 
α,β-unsaturated carbonyl moiety that together form the pharmacophore responsible for 
calpain protease inhibition38. Thus, the assembly line constructs a series of chemical 
products in which the structural elements that confer activity are maintained, while 
accessory elements such as the fatty acid and linear chain composition and length, which 
may confer target specificity, are variable. It has been speculated that biosynthetic 
promiscuity resulting in chemical diversity may be evolutionarily advantageous39,40. 
Furthermore, the type of combinatorial biosynthesis observed in this study expands the 
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portfolio of small molecules produced without introducing new assembly line modules or 
domains, or even additional tailoring enzymes, thus representing a means of expanding 
chemical diversity while minimizing genomic space.
Our work was facilitated by new methodology combining oligo recombineering with 
CRISPR-Cas9 counter selection for facile editing of large DNA constructs. Although our 
method was used solely for domain inactivation in this study, it can be easily applied to 
perform other forms of multi-modular assembly line engineering, for example to alter A 
domain specificity41,42. Future efforts to understand the specific elements that enable and 
control assembly line flexibility will hopefully enhance efforts to engineer NRPS/PKS 
proteins and possibly expand their biosynthetic repertoire.
Methods
General methods.
A complete list of the primers, plasmids, and strains used in this study can be found in 
Supplementary Table 3. DNA fragments larger than 3 kb were amplified with PrimeSTAR 
Max (Clontech Laboratories, Inc.); all other PCR products were amplified with PrimeSTAR 
HS DNA polymerase (Clontech Laboratories, Inc.). DNA isolations and manipulations were 
carried out using standard protocols. Thalassospira sp. CNJ-328 and T. mobilis 
KA081020-065 were grown in GYP media (glucose 10 g/L, yeast extract 4 g/L, peptone 2 
g/L, sea salt 25 g/L). S. cerevisiae VL6-48N was grown in YPDA media (yeast extract 10 
g/L, peptone 20 g/L, dextrose 20 g/L, adenine 100 mg/L) or selective histidine drop-out 
media containing 5-FOA (yeast nitrogen base without amino acids and ammonium sulfate 
1.7 g/L, yeast synthetic dropout medium without histidine 1.9 g/L, sorbitol 182 g/L, dextrose 
20 g/L, ammonium sulfate 5 g/L, adenine 100 mg/L, 5-FOA 1 g/L). E. coli and P. putida 
strains were grown in LB. E. coli TOP10 and DH5α λpir were used for standard cloning 
procedures. E. coli BW25113/pIJ790 was used for λ Red PCR targeting, and E. coli HME68 
was used for oligo recombineering and CRISPR-Cas9 counter selection. P. putida EM383 
was used for heterologous expression. All strains were grown at 30 °C except TOP10 and 
DH5α λpir, which were grown at 37 °C. Liquid cultures were grown shaking at 220 r.p.m. 
When necessary, E. coli (and P. putida) cultures were supplemented with the following 
antibiotics: 50 μg/mL kanamycin (150 μg/mL for P. putida), 10 μg/mL gentamycin (30 μg/ml 
for P. putida), 50 μg/mL apramycin, 100 μg/mL ampicillin, 25 μg/mL chloramphenicol.
Cloning and heterologous expression of ttc and ttm.
The overall workflow for genetic manipulation and heterologous expression of the ttc and 
ttm pathways is outlined in Supplementary Fig. 1. Biosynthetic gene clusters were cloned 
from genomic DNA using a TAR cloning protocol described previously43. Cluster-specific 
capture vectors were generated through a one-step PCR amplification of pCAP-BAC (pCB) 
using primers pCB-ttcCV_F/R for ttc and pCB-ttmCV_F/R for ttm. Yeast clones were 
screened, and PCR positive constructs were purified and transferred to E. coli TOP10 for 
verification by restriction digestion. pCB was miniprepped from at least 25 mL of VL6-48N 
and at least 10 mL of TOP10. Expression was attempted but never achieved in E. coli 
strains, including BL21(DE3) and BAP144 (Supplementary Fig. 2). pJZ001, containing the 
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intB13 cassette, was assembled by Gibson Assembly using four PCR fragments (amplified 
using primers CEN6/ARS4_608F/R, intB13_2330F/R, aacC1_1257F/R, and 
pADH_597F/R) and the pACYCDuet-1 vector backbone, linearized using HindIII and XhoI. 
Fully assembled pJZ001 was digested using HindIII and XhoI, and the 5155 bp fragment 
was gel purified and used for λ Red recombination45 to knock-in the intB13 cassette into the 
pCB vector backbone, replacing several yeast genes no longer necessary. Retrofitted 
constructs were then transferred to P. putida by electroporation as described previously16 and 
selected for using kanamycin and gentamicin. IntB13-mediated integration of ttc into the 
genome of P. putida was characterized by PCR and chemical analysis (Supplementary Fig. 
3). Edited constructs were similarly introduced to P. putida and then tested for heterologous 
production of lipopeptide products.
Extraction and LC-MS analysis.
Precultures were inoculated with colonies picked from plates and grown overnight before 
being inoculated into full 50 mL cultures in 250 mL Erlenmeyer flasks (in triplicate). Full 
cultures were grown for 5 hours before addition of 1.5 g of autoclaved XAD7HP resin per 
50 mL of culture. After 24 hours of additional incubation, culture ODs were measured and 
recorded at 600 nm and supernatant and cells were decanted. Resin was washed three times 
with Milli-Q water before extraction with 20 mL of ethyl acetate. Extracts were dried under 
nitrogen, resuspended in 200 μL of methanol, and filtered through a 0.22 μm filter prior to 
LC-MS-MS analysis.
An Agilent 1100 series HPLC system (Palo Alto, CA, U.S.A.) was coupled to a Bruker 
Impact II Q-TOF mass spectrometer (Billerica, MA, U.S.A.) for LC-MS analysis. An 
Agilent ZORBAX 300SB-C18 LC column (300 Å, 5 μm, 150 × 0.5 mm) was used for LC 
separation. Mobile phase A was H2O in 0.1% FA and mobile phase B was ACN in 0.1% FA. 
The LC gradient was: t=0.00 min, 70%A; t=3.00 min, 70%A; t=5.00 min, 57%A; t=35.00 
min, 57%A; t=49.00 min, 20%A; t=51.00 min, 0%A; t=52.00 min, 0%A; t=57.00 min, 
70%A; t=60.00 min, 70%A. A post time of 10 min was set to re-equilibrate the column. For 
shorter runs, the LC gradient was: t=0.00 min, 70%A; t=3.00 min, 70%A; t=23.00 min, 
20%A; t=24.00 min, 0%A; t=27.00 min, 70%A; t=30.00 min, 70%A. A post time of 3 min 
was set to re-equilibrate the column. Flow rate was 20 μL/min. Sample injection volume was 
2 μL.
MS conditions for MS/MS spectra generation were set as follows: capillary voltage, 4500; 
nebulizer gas flow, 0.8 Bar; dry gas, 5.0 L/min at 180 ºC; funnel 1 RF 150 Vpp; funnel 2 RF, 
300 Vpp; isCID energy, 0 eV; hexapole RF: 50 Vpp; Quadrupole ion energy, 4 eV; low mass 
50 m/z; collision cell energy, 20 – 50 eV; pre pulse storage 5.0 μs; collision RF, ramp from 
350 to 800 Vpp; transfer time ramp from 50 to 100 μs; detection mass range 25 to 1000 m/z; 
MS/MS spectra collection rate was 2.0 Hz.
All samples analyzed by comparison were run at the same time and under the same 
conditions. Values were normalized by culture ODs and compared only for peaks with 
identical MS spectra and retention time. HR-MS data for thalassospiramide analogs 
analyzed in this study are provided in Supplementary Table 2 and Supplementary Fig. 12-24.
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Gene deletion and complementation experiments.
Gene deletions were made using λ Red PCR targeting as described previously46. Primers 
used to amplify the aac(3)IV cassette and confirm gene deletions are listed in Supplementary 
Table 3. Deletions using this cassette were made after addition of the intB13 cassette, which 
contains a gentamycin resistance gene, as the apramycin resistance gene aac(3)IV confers 
resistance to gentamycin in E. coli. For complementation, ttcD and ttcC were amplified 
using primers Tn7-ttcD_F/R and Tn7-ttcC_F/R, respectively, and cloned into the mini-Tn7 
vector pUC18R6K-mini-Tn7T-Gm47. Cloned constructs were introduced to P. putida by 
electroporation16 along with the helper plasmid pTNS147 and selected for using gentamycin. 
Complemented P. putida clones were then made electrocompetent and pCB constructs were 
transferred by electroporation and selected for using kanamycin and gentamycin. For 
complementation of TtcC-G234D (MT6 inactivation), the mutation was generated by 
amplification of pTn7::ttcC using primers Tn7-ttcC-g702a_F/R and confirmed by 
sequencing. Although a ttcA deletion construct was generated and a mini-Tn7 vector 
containing ttcA was prepared, the latter ultimately could not be transferred to P. putida for 
complementation, as no clones were obtained even after multiple attempts, likely due to the 
large size of the gene (>6.5 kb).
Inactivation and testing of assembly line enzymatic domains.
Assembly line domain active sites are shown in Supplementary Fig. 8. Motifs and active 
sites were identified by sequence alignment against annotated NRPS/PKS 
domains22-24,48-55. pJZ002, an ampicillin resistant version of the pCas956 vector, was 
constructed as follows. First, the BsaI restriction site was first removed from the ampicillin 
resistance gene bla via PCR amplification of pKD20 using primers pKD20-g848a_F/R. The 
resulting construct was PCR amplified using primers ts-repA101_F/R and combined with a 
fragment amplified from pCas9 using primers pCas9_5058F/R by Gibson assembly. Spacer 
sequences were cloned into pJZ002 as described previously56. Spacer sequences and 
targeting oligos used to target specific domains are listed in Supplementary Table 3. Oligo 
recombination and CRISPR-Cas9 counter selection were performed as described 
previously56,57, with several modifications. The general workflow is shown in 
Supplementary Fig. 10. pCB constructs were first transferred to E. coli HME68 by 
electroporation and selected for using kanamycin. A transformant was picked and grown at 
30 °C to OD600 0.4-0.5 and heat shocked for 15 minutes at 42 °C in a shaking water bath 
before being chilled on ice for 10 minutes. The cells were pelleted and washed with ice-cold 
water before being resuspended in a small volume of ice-cold water. 100 ng of pJZ002 
containing the appropriate spacer was mixed with 100 ng of targeting oligo and the DNA 
mixture was introduced to the cells prior to electroporation at 2.5 kV in a 2 mm gap 
electroporation cuvette. Cells were recovered for 2 hours at 30 °C shaking and plated on LB 
with kanamycin and ampicillin. Four clones of each mutant were picked, miniprepped, and 
screened by sequencing. If no correct mutant was identified, a new spacer sequence was 
designed and cloned into pJZ002 and the method was retried. Very subtle mutations could be 
recovered efficiently using an effective spacer sequence, although the effectiveness of the 
spacer could only be determined empirically. In total, four of 12 spacer sequences were 
redesigned to achieve successful editing (Supplementary Table 3). Correctly edited 
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constructs were transferred to TOP10 and confirmed by restriction digestion (Supplementary 
Fig. 11) before being transferred to P. putida for heterologous expression.
Data availability
The ttc and ttm biosynthetic gene cluster sequences are available in the MIBiG database 
(accession BGC0001050 and BGC0001876). Plasmids pCAP-BAC (#120229), pJZ001 
(#120230), and pJZ002 (#120231) are available at Addgene.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1 ∣. Heterologous reconstitution of thalassospiramide biosynthetic gene clusters in a P. putida 
host.
a,b, Annotated genomic loci encompassing the thalassospiramide assembly line genes from 
Thalassospira sp. CNJ-328 (a) and Tistrella mobilis KA081020-065 (b) targeted for cloning 
and heterologous expression. (c) LC-MS analysis of extracts from an empty P. putida 
EM383 host and hosts with genomically integrated ttc and ttm pathways compared against 
an authentic thalassospiramide A (1) standard. Extracted ion chromatograms (EIC) of m/z 
958.5496. See Supplementary Fig. 4 for associated MS/MS spectra.
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Fig. 2 ∣. Ttc and Ttm assembly lines and structures of associated cyclic lipodepsipeptide 
products.
(a) Ttc assembly line and structures of a representative set of associated chemical products. 
(b) Ttm assembly line and representative associated chemical products. Analogs not 
previously reported are underlined; see Supplementary Table 2 for HR-MS data. Analogs 
detected by LC-MS from the native producer but not the heterologous host are marked with 
an asterisk. C, condensation; A, adenylation; T, thiolation; KS, ketosynthase; AT, 
acyltransferase; DH, dehydratase; KR, ketoreductase; MT, methyltransferase; TE, 
thioesterase.
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Fig. 3 ∣. Selective inactivation of assembly line enzymatic domains alters product formation.
a,b, Changes in production level of thalassospiramide analogs from Ttc (a) and Ttm (b) 
assembly lines upon selective inactivation of specific enzymatic domains. Domain and 
precise amino acid mutations are listed in the first two columns. Fold-change in MS ion 
intensity is indicated by number and color intensity, while white boxes indicate analogs were 
not detected (n.d.) from the mutant. Statistical significance was calculated using a two-tailed 
Student’s t-test; n=3 biologically independent samples, *p<0.05, **p<0.005. (c) Structures 
and EICs of new thalassospiramide analogs produced upon TtmA C2 inactivation; see 
Supplementary Table 2 for HR-MS data.
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Fig. 4 ∣. Model for thalassospiramide biosynthesis by Ttm C2 inactivation mutant.
Valine is loaded onto T1 by A2 and C1 catalyzes addition of an activated fatty acid (FA) 
bound to an acyl carrier protein (ACP) or coenzyme A. Module 2 is skipped, and the fatty 
valine is extended directly onto serine-loaded T3 via C3. Chain extension proceeds normally 
to module 4, where the substrate is not immediately dehydrated and would normally be 
passed back to module 2 via C2, perhaps based on chain length. However, C2 inactivation 
forces the intermediate forward, where it becomes transiently accessible to DH4 and is 
dehydrated before extension onto T5, which is loaded with valine by A2. Direct progression 
through module 6 results in formation of thalassospiramide E4 (25), which is substantially 
increased as a result of C2 inactivation. Alternatively, passage from module 5 back to 
module 3 results in generation of new thalassospiramide analogs E5 (27) and E6 (28), which 
undergo one or two additional rounds of chain extension, respectively, through modules 3-5.
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Fig. 5 ∣. Model for thalassospiramide A biosynthesis by Ttc.
Serine is loaded onto T1a by A3, and C1a catalyzes addition of an activated fatty acid (FA) 
bound to an ACP or coenzyme A. Module 1b is skipped, and the fatty serine is passed 
directly to valine-loaded T2 via C2. Chain extension proceeds normally to module 4, where 
the substrate is sequestered from DH4, perhaps within an enzyme binding pocket. The 
intermediate is passed from module 4 back to module 2 via C2, where it undergoes another 
round of chain extension through modules 3 and 4. Upon return to module 4, the 
intermediate is now acted upon by DH4, perhaps due to a conformational change associated 
with longer chain length, and extended forward through modules 5 and 6 to generate 
thalassospiramide A (1).
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